Dopaminergic effects on simple and choice reaction time performance in Parkinson's disease.
about
Catecholamines and cognition after traumatic brain injuryThe Human Experience with Intravenous LevodopaPathophysiology of cerebellar ataxiaMovement amplitude choice reaction time performance in Parkinson's disease may be independent of dopaminergic status.Dopaminergic induced changes in cognitive and motor processing in Parkinson's disease: an electrophysiological investigation.The effect of withdrawal of dopaminergic medication on simple and choice reaction time and the use of advance information in Parkinson's diseasePreparation of manual movements in hemiparkinsonism.A double-blind, placebo-controlled study on the effects of lutein and zeaxanthin on neural processing speed and efficiencyNeuropsychology for movement disorders neurosurgery.Cognitive slowing in Parkinson's disease resolves after practice.Optokinetic nystagmus reflects perceptual directions in the onset binocular rivalry in Parkinson's diseaseDeep brain stimulation of the subthalamic nucleus, but not dopaminergic medication, improves proactive inhibitory control of movement initiation in Parkinson's diseaseImpaired automatic and unconscious motor processes in Parkinson's diseaseCognitive components of reaction time in Parkinson's disease.A comparative study of simple and choice reaction time in Parkinson's, Huntington's and cerebellar diseaseChronic effects of dopaminergic replacement on cognitive function in Parkinson's disease: a two-year follow-up study of previously untreated patients.Abnormal refractoriness in patients with Parkinson's disease after brief withdrawal of levodopa treatmentCoding of movement direction and amplitude in Parkinson's disease: are they differentially impaired (or unimportant)?Programming of single movements in Parkinson's disease: comparison with Huntington's disease.Driving with Parkinson's disease. A controlled laboratory investigation.Practice effects on the preprogramming of discrete movements in Parkinson's diseaseOrder effects in response times of parkinsonian patients and normal controls.Orbitofrontal (18) F-DOPA Uptake and Movement Preparation in Parkinson's Disease.On the peculiarity of simple reaction time.Impairment of high-contrast visual acuity in Parkinson's disease.Differential response in choice reaction time following apomorphine based on prior dopaminergic treatment.Impairment of eyeblink classical conditioning in progressive supranuclear palsy.Recency-primacy recognition in Parkinson's disease.Impact of deep brain stimulation on upper limb akinesia in Parkinson's disease.The effects of posteroventral pallidotomy on the preparation and execution of voluntary hand and arm movements in Parkinson's disease.Frontal cognitive impairments and saccadic deficits in low-dose MPTP-treated monkeys.High-speed memory scanning in Parkinson's disease: adverse effects of levodopa.Gait initiation in Parkinson's disease.Audiovisual Processing is Abnormal in Parkinson's Disease and Correlates with Freezing of Gait and Disease Duration.Hypothesis: the bradyphrenia of parkinsonism is a nosological entity.Motor program memory storage in Parkinson's disease patients tested with a delayed response task.Minimum cortical processing time.The basal ganglia network mediates the planning of movement amplitude.Slowing of high-speed memory scanning in Parkinson's disease is related to the severity of parkinsonian motor symptoms.Allocation of attention to programming of movement sequences in Parkinson's disease.
P2860
Q26743582-181B6E0A-5BF1-4318-9D47-4B373CFF9C3EQ26771516-AFA52613-38EC-49FD-B09D-5567AAF29655Q28246093-DD392184-BBB3-48C3-8081-97A3080B3F53Q33588807-0C07CB11-D4EA-4A5E-B908-A88F81353DEFQ33589547-DD9E6B0A-41BE-4B2E-837F-9067837289EEQ33592173-5231A2D7-BC88-448F-A546-E718272519B9Q33629460-254A37E5-0BE0-4954-9E55-798501616D60Q34252798-9C0DC540-3EB5-448E-A748-0C39253EBF7DQ35105765-6083D385-0199-4026-9EF1-A11E5576F693Q35469822-E83D7613-5682-4BF8-B113-3A67448BA705Q36306312-908BFA18-88B5-4021-A373-B8E656E73203Q36568655-EF3FD0BE-DC5E-4416-BB5D-2A2D25D91AA2Q36963447-1FC8FA15-C511-4774-9D57-19F69D82A3A1Q36966055-3263B60A-2E9A-49BA-ABD4-2DD9D078C36EQ36981565-DE504499-AE95-40EC-9DB3-1707DDC551E8Q38444112-081F09F4-A69E-400A-9693-9395DBA5F86FQ40928741-6440840C-596C-463C-AD3D-B4ABDDC8316BQ41083562-8DDA179F-97B4-466B-97E1-E275B8402411Q41108601-4343418B-72A2-4B5A-8205-6A79E24E47D4Q41113570-C809F4F3-C640-40D6-A342-027F16E1A1ADQ41370430-973FD960-255F-4462-A6F8-983EAAC6E6C1Q41665636-339EE881-FD69-42D5-AEAF-428BC584A2EEQ42405592-0798B97A-27A5-4070-8629-31F5D45801D1Q43751382-8FF983F9-CF67-4942-86D8-9D259E08DD81Q44111226-8CCE7BC4-20CD-4B5E-A083-C4E654140B59Q44841414-82929D43-F70A-4CF6-8B8E-D201E70D36D2Q45949075-34528C64-D069-46B8-A52D-DF12AA2DDBCBQ46039161-523027E0-751C-42C4-B9E3-31C3871CFD34Q48231824-186E682A-5640-4204-A8F1-CD7A59CC3B5EQ48267620-C99228B8-DB5D-46BF-B3F8-1579E502EE6BQ48276333-B3C3CEC8-889B-4DE9-A4AE-0D02D14A40AAQ48713181-6525E3CE-123D-4A89-B34C-E8124324EC74Q49108311-C85E17D6-3E9F-4DD2-9011-D98950DF5284Q50788739-1A88260F-2D8F-46FF-AB4A-C47E4D487710Q52036841-8E27C29B-8A28-4634-B5DD-54CBDE03DE3FQ52058617-FB02AED4-9CD3-4375-8075-C44D2169B6A3Q52060158-3AFB8CE8-48BB-414F-B4DA-24507E901724Q52089498-441EFC85-D4E4-452F-8FF0-B546261E3357Q52112092-E8A3F8C9-1BBC-43F4-8AFF-F92295447909Q52218806-30E6E7EC-BAE3-4FF1-9D48-82899E81AABB
P2860
Dopaminergic effects on simple and choice reaction time performance in Parkinson's disease.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh-hant
name
Dopaminergic effects on simple ...... rmance in Parkinson's disease.
@en
Dopaminergic effects on simple ...... rmance in Parkinson's disease.
@nl
type
label
Dopaminergic effects on simple ...... rmance in Parkinson's disease.
@en
Dopaminergic effects on simple ...... rmance in Parkinson's disease.
@nl
prefLabel
Dopaminergic effects on simple ...... rmance in Parkinson's disease.
@en
Dopaminergic effects on simple ...... rmance in Parkinson's disease.
@nl
P2093
P356
P1433
P1476
Dopaminergic effects on simple ...... rmance in Parkinson's disease.
@en
P2093
P304
P356
10.1212/WNL.38.2.249
P407
P577
1988-02-01T00:00:00Z